These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28585001)

  • 1. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
    Segal E
    Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
    Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral vaccine against candidiasis generated by a yeast molecular display system.
    Shibasaki S; Aoki W; Nomura T; Miyoshi A; Tafuku S; Sewaki T; Ueda M
    Pathog Dis; 2013 Dec; 69(3):262-8. PubMed ID: 23873745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
    Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
    Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
    Xin H
    Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
    Singh S; Uppuluri P; Mamouei Z; Alqarihi A; Elhassan H; French S; Lockhart SR; Chiller T; Edwards JE; Ibrahim AS
    PLoS Pathog; 2019 Aug; 15(8):e1007460. PubMed ID: 31381597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.
    Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B
    PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
    Han Y; Rhew KY
    Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis.
    Shibasaki S; Aoki W; Nomura T; Karasaki M; Sewaki T; Ueda M
    Biocontrol Sci; 2014; 19(1):51-5. PubMed ID: 24670619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.
    Sui X; Yan L; Jiang YY
    Vaccine; 2017 Oct; 35(43):5786-5793. PubMed ID: 28911903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective antigens and mechanisms of anti-Candida immunity.
    Antonio C
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes.
    Segal E; Nussbaum S; Barr-Nea L
    Sabouraudia; 1985 Aug; 23(4):275-85. PubMed ID: 3901330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
    Xin H; Cutler JE
    Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
    Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).
    Cárdenas-Freytag L; Steele C; Wormley FL; Cheng E; Clements JD; Fidel PL
    Med Mycol; 2002 Jun; 40(3):291-9. PubMed ID: 12146759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.